Recent studies identified significant changes in PER2 expression in tumors such as chronic lymphocytic leukemia, kidney cancer, head and neck squamous cell carcinoma, and colorectal cancer (Momma et al., 2017; Xiong et al., 2018; Qiu et al., 2019; Wang et al., 2020). Here, PER2 is linked to colorectal cancer.